Effects of rosuvastatin on glomerular capillary size-selectivity function in rats with renal mass ablation (Q47270697)

From Wikidata

Jump to navigation Jump to search

scientific article published on 11 September 2007

Language	Label	Description	Also known as
English	Effects of rosuvastatin on glomerular capillary size-selectivity function in rats with renal mass ablation	scientific article published on 11 September 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17851231

Effects of rosuvastatin on glomerular capillary size-selectivity function in rats with renal mass ablation (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17851231

object named as

Ariela Benigni

8

0 references

object named as

Andrea Remuzzi

6

0 references

Giuseppe Remuzzi

object named as

Giuseppe Remuzzi

10

0 references

3

object named as

Dario Cattaneo

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17851231

Norberto Perico

9

object named as

Norberto Perico

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17851231

7

object named as

Carla Zoja

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17851231

1

object named as

Daniela Corna

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17851231

5

object named as

Flavio Gaspari

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17851231

Fabiola Carrara

4

object named as

Fabiola Carrara

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17851231

2

object named as

Fabio Sangalli

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17851231

publication date

11 September 2007

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17851231

American Journal of Nephrology

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17851231

27

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17851231

6

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17851231

630-638

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17851231

Angiotensin-converting enzyme inhibition and angiotensin II antagonism in nondiabetic chronic nephropathies

1 reference

https://api.crossref.org/works/10.1159%2F000108359

21 January 2018

Effect of lipid reduction on the progression of renal disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1159%2F000108359

21 January 2018

Effect of combining ACE inhibitor and statin in severe experimental nephropathy

1 reference

https://api.crossref.org/works/10.1159%2F000108359

21 January 2018

How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approach

1 reference

https://api.crossref.org/works/10.1159%2F000108359

21 January 2018

Rosuvastatin-induced arrest in progression of renal disease

1 reference

https://api.crossref.org/works/10.1159%2F000108359

21 January 2018

Inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase reduce receptor-mediated endocytosis in opossum kidney cells

1 reference

https://api.crossref.org/works/10.1159%2F000108359

21 January 2018

Inhibitors of HMG-CoA reductase reduce receptor-mediated endocytosis in human kidney proximal tubular cells

1 reference

https://api.crossref.org/works/10.1159%2F000108359

21 January 2018

Effects of HMG-CoA reductase inhibition on hepatic expression of key cholesterol-regulatory enzymes and receptors in nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1159%2F000108359

21 January 2018

Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies

1 reference

https://api.crossref.org/works/10.1159%2F000108359

21 January 2018

Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects

1 reference

https://api.crossref.org/works/10.1159%2F000108359

21 January 2018

Identifiers

10.1159/000108359

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17851231

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/17851231

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47270697&oldid=2149644507"